The Effect of an Intravitreal Triamcinolone Acetonide Injection for Acute Nonarteritic Anterior Ischemic Optic Neuropathy
Korean Journal of Ophthalmology
; : 59-61, 2009.
Article
in En
| WPRIM
| ID: wpr-39305
Responsible library:
WPRO
ABSTRACT
The purpose of this case report is to evaluate the visual outcome of an intravitreal triamcinolone acetonide injection (IVTA) as a treatment for a patient with acute nonarteritic anterior ischemic optic neuropathy (NAION). A 65-year-old male patient with severe visual loss due to acute NAION was treated with 4 mg/0.1mL IVTA. Fundus examination and measurements of the patient's best-corrected visual acuity and visual field were performed before and after the injection at 2 weeks, 1 month, 3 months, and 6 months. The best-corrected visual acuity changed from 0.05 before the injection to 0.16 at 2 weeks, 0.3 at 1 month, and 0.4 at 3 months and at the final visit. Optic disc swelling had markedly decreased at 1 week postoperatively and disappeared at 2 weeks after the injection. The clinical course of this patient suggests that an IVTA may be effective in increasing visual acuity following an acute NAION. A large randomized controlled trial is needed to assess the efficacy of IVTA as a treatment for NAION.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Ophthalmic Solutions
/
Vitreous Body
/
Triamcinolone Acetonide
/
Fluorescein Angiography
/
Visual Acuity
/
Visual Fields
/
Acute Disease
/
Follow-Up Studies
/
Optic Neuropathy, Ischemic
/
Diagnosis, Differential
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Humans
/
Male
Language:
En
Journal:
Korean Journal of Ophthalmology
Year:
2009
Type:
Article